Published: 24-09-2024
Review
WASOG 2023 conference highlights
Abstract 67 | PDF Downloads 43Page e2024046
Inhaled budesonide and pulmonary sarcoidosis revisited
Abstract 91 | PDF Downloads 72Page e2024037
Echocardiographic evaluation of left ventricular mechanics in sarcoidosis patients without overt heart disease: a systematic review and meta-analysis
Abstract 85 | PDF Downloads 64Page e2024042
Original Articles: Clinical Research
Scar sarcoidosis: Clinical features and prognostic significance
Abstract 56 | PDF Downloads 41Page e2024046
Central Nervous System Sarcoidosis: A National-Based registry study
Abstract 81 | PDF Downloads 60Page e2024040
Hydroxychloroquine monotherapy in sarcoidosis: Indications, efficacy, and side effects
Abstract 99 | PDF Downloads 67Page e2024039
Are the gains from pulmonary rehabilitation the same in idiopathic pulmonary fibrosis and other interstitial lung diseases?
Abstract 91 | PDF Downloads 83Page e2024038
Interstitial Lung Disease in Primary Sjögren’s Syndrome: Risk factors for occurrence and radiographic progression
Abstract 97 | PDF Downloads 67Page e2024035
The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey
Abstract 106 | PDF Downloads 80Page e2024047
Assessment of quality of life in IPF Patients: a multicenter observational study
Abstract 79 | PDF Downloads 52Page e2024043
Original Articles: Laboratory Research
Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through AKT-mTOR pathway
Abstract 60 | PDF Downloads 50Page e2024034
Case Reports
Case of familial interstitial lung disease attributed to ATP-binding cassette transporter 3 gene mutation in identical twins
Abstract 50 | PDF Downloads 41Page e2024033
Letter to Editor
The fissural involvement in pleuroparenchymal fibroelastosis: Something beyond the alveolar elastosis
Abstract 39 | PDF Downloads 39Page e2024041